Neurogene Inc. Common Stock
NGNE
Closed
$43.44
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in New York City, New York and currently employs 131 full-time employees. The company went IPO on 2014-03-07.
Key stats
Open
$37.94
Volume
436.66K
Market cap
$762.00M
Prev. close
$42.84
Impl / hst vl
-
Open interest
$0.00
$37.87
Day’s Range
$43.66
$15.93
52W Range
$39.30
Valuation
33
Valuation score
Overvalued
P/E
-
P/S
-
P/B
3.15
Current ratio
13.08
Debt / Equity
-0.52
ROE
-
Gross margin
-
Income growth
-
FCF growth
50.37
Analysts estimates
Consensus rating
Buy
The average rating from top 8 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$81.60
The top 9 analysts forecasts that 12-month price may increase by 87.85%, with a low of $46.46 and a high of $189.00
$46.46
Low
$81.60
Avg
$189.00
High
Current price
Earnings
Q4 ‘25 revenue
$0.00
Q4 ‘25 net income
-$24.74M
Revenue
Net income
Previous EPS
-$1.39
Estimate EPS
-$1.46
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply